vigabatrin (Q421663)

From Wikidata

Jump to navigation Jump to search

an antiepileptic drug

CPP-109
MDL-71754
Sabril®
gamma-vinyl-gamma-aminobutyric acid
gamma-vinyl GABA
GVG
4-Amino-5-hexenoic acid
gamma-Vinyl-gamma-aminobutyric acid
Vinyl gamma-aminobutyric acid
gamma-Vinyl GABA
Vigabatrina
Vigabatrin
Gamma vinyl GABA
Vigabatrine
Vigabatrinum

Language	Label	Description	Also known as
English	vigabatrin	an antiepileptic drug	CPP-109 MDL-71754 Sabril® gamma-vinyl-gamma-aminobutyric acid gamma-vinyl GABA GVG 4-Amino-5-hexenoic acid gamma-Vinyl-gamma-aminobutyric acid Vinyl gamma-aminobutyric acid gamma-Vinyl GABA Vigabatrina Vigabatrin Gamma vinyl GABA Vigabatrine Vigabatrinum

Statements

type of chemical entity

0 references

carboxylic acid

0 references

0 references

chemical structure

Vigabatrin Enantiomers Structural Formulae.png
1,693 × 1,758; 13 KB

1 reference

imported from Wikimedia project

German Wikipedia

Vigabatrin2DCSD.svg
819 × 419; 7 KB

0 references

image of molecular model or crystal lattice model

Vigabatrin ball-and-stick.png
2,000 × 1,440; 293 KB

ball-and-stick model

0 references

129.078979 dalton

1 reference

language of work or name

vigabatrin (English)

3 October 2016

chemical formula

C₆H₁₁NO₂

1 reference

language of work or name

vigabatrin (English)

19 November 2016

canonical SMILES

C=CC(CCC(=O)O)N

1 reference

language of work or name

vigabatrin (English)

19 November 2016

defined daily dose

2 gram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N03AG04

active ingredient in

1 reference

14 February 2018

World Health Organisation international non-proprietary name

vigabatrin (English)

1 reference

language of work or name

vigabatrin (English)

3 October 2016

medical condition treated

temporal lobe epilepsy

1 reference

Drug Indications Extracted from FAERS

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

tuberous sclerosis 1

1 reference

Drug Indications Extracted from FAERS

2 October 2018

20 August 2009

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/GR120KRT6K

http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020427s000lbl.pdf

pregnancy category

Australian pregnancy category D

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category D

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Vigabatrin

31 July 2020

subject has role

enzyme inhibitor

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

15 March 2018

anticonvulsant agent

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

Commons category

Vigabatrin

0 references

Identifiers

InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)

1 reference

language of work or name

vigabatrin (English)

19 November 2016

PJDFLNIOAUIZSL-UHFFFAOYSA-N

2 references

language of work or name

vigabatrin (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

reason for deprecated rank

withdrawn identifier value

0 references

0 references

1 reference

language of work or name

Vigabatrin (English)

19 November 2016

1 reference

language of work or name

vigabatrin (English)

19 November 2016

mapping relation type

3 references

language of work or name

VIGABATRIN (English)

19 November 2016

ChEBI release 2019-10-02

matched by identifier from

International Chemical Identifier

InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)

1 reference

language of work or name

VIGABATRIN (English)

19 November 2016

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

PJDFLNIOAUIZSL-UHFFFAOYSA-N

UniChem compound ID

1 reference

MassBank accession ID

MSBNK-Eawag-EQ362601

0 references

MSBNK-Eawag-EQ362602

0 references

MSBNK-Eawag-EQ362603

0 references

MSBNK-Eawag-EQ362604

0 references

MSBNK-Eawag-EQ362605

0 references

MSBNK-Eawag-EQ362606

0 references

MSBNK-Eawag-EQ362607

0 references

MSBNK-Eawag-EQ362608

0 references

MSBNK-Eawag-EQ362609

0 references

MSBNK-Waters-WA000440

0 references

MSBNK-Waters-WA000441

0 references

MSBNK-Waters-WA000442

0 references

splash10-00di-9400000000-c7d21d36dfb8e7079ee2

0 references

splash10-00di-9200000000-e0c504f980ef5bbc0501

0 references

splash10-00di-9000000000-e1b2ea8d5a2da84a5a64

0 references

splash10-00di-9000000000-52958176067fd9bae916

0 references

splash10-00di-9000000000-263da4b132ca66986967

0 references

splash10-01b9-9000000000-1f8826cc32ef269c1a7c

0 references

splash10-014i-9000000000-32306e2f90cd529accc7

0 references

splash10-0gb9-9000000000-aefa9f2682087c7b78ed

0 references

DSSTox substance ID

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

matched by identifier from

PJDFLNIOAUIZSL-UHFFFAOYSA-N

DSSTOX compound identifier

0 references

0 references

0 references

ECHA Substance Infocard ID

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

4-aminohex-5-enoic acid (English)

CAS no.: 60643-86-9 (English)

1 reference

language of work or name

Vigabatrin (English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

vigabatrin (English)

19 November 2016

MeSH descriptor ID

subject named as

Vigabatrin

0 references

D02.241.081.114.500.350.900

0 references

D12.125.190.350.900

0 references

1 reference

Global Substance Registration System

language of work or name

vigabatrin (English)

19 November 2016

1 reference

matched by identifier from

PJDFLNIOAUIZSL-UHFFFAOYSA-N

Human Metabolome Database ID

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

PJDFLNIOAUIZSL-UHFFFAOYSA-N

2 references

Global Substance Registration System

language of work or name

vigabatrin (English)

19 November 2016

matched by identifier from

PJDFLNIOAUIZSL-UHFFFAOYSA-N

MedlinePlus drug identifier

0 references

1 reference

Global Substance Registration System

language of work or name

vigabatrin (English)

19 November 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

vigabatrin (English)

3 October 2016

1 reference

Freebase Data Dumps

publication date

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

Global Substance Registration System

language of work or name

vigabatrin (English)

19 November 2016

WikiProjectMed ID

0 references

Sitelinks

Wikipedia(18 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswiki Category:Vigabatrin

Retrieved from "https://www.wikidata.org/w/index.php?title=Q421663&oldid=2266331019"